Clincosm LogoSign in Get a demo

advanced non small cell lung cancer

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • (no location specified)
Oct 24, 2023

Advanced Non Small Cell Lung Cancer Trial run by the National Cancer Institute (NCI) (aerosolized aztreonam, aerosolized

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • aerosolized aztreonam
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 28, 2023

Advanced Non Small Cell Lung Cancer Trial in Worldwide (ATL001, Pembrolizumab)

Recruiting
  • Advanced Non Small Cell Lung Cancer
  • New Haven, Connecticut
  • +16 more
Jan 6, 2023

Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Advanced Non Small Cell Lung Cancer
  • Advanced (Inoperable) Non Small Cell Lung Cancer
  • Aurora, Colorado
  • +44 more
Aug 17, 2022

Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer Trial in Worldwide (MRTX849, Docetaxel)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Advanced Non Small Cell Lung Cancer
  • Santa Rosa, California
  • +141 more
Aug 10, 2022

Advanced Non Small Cell Lung Cancer Trial in Changchun, Shanghai, Hangzhou (D-0316)

Active, not recruiting
  • Advanced Non Small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
Apr 29, 2022

Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic

Active, not recruiting
Has Results
  • Advanced Non Small Cell Lung Cancer
  • Advanced (Inoperable) Non Small Cell Lung Cancer
  • Pharmacokinetic sampling
  • +2 more
  • San Diego, California
  • +15 more
Feb 21, 2022

Melanoma, Advanced Non Small Cell Lung Cancer Trial in United Kingdom, United States (Long-Term Follow-Up of Patients who

Not yet recruiting
  • Melanoma
  • Advanced Non Small Cell Lung Cancer
  • Long-Term Follow-Up of Patients who Received ATL001
  • Tampa, Florida
  • +9 more
Feb 15, 2022

Advanced Non Small Cell Lung Cancer Trial in Changsha (Toripalimab combination with platinum-containing dual-drug chemo)

Recruiting
  • Advanced Non Small Cell Lung Cancer
  • Toripalimab combination with platinum-containing dual-drug chemotherapy
  • Changsha, Hunan, China
    Hunan Provincal Tumor Hospital
Dec 28, 2021

Advanced Non Small Cell Lung Cancer Trial in Jinan (Almonertinib plus microwave ablation)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • Almonertinib plus microwave ablation
  • Jinan, Shandong, China
    Xin Ye
Sep 2, 2021

Advanced Non Small Cell Lung Cancer Trial in France (Nivolumab + Ipilimumab, Chemotherapy)

Active, not recruiting
  • Advanced Non Small Cell Lung Cancer
  • Aix-en-Provence, France
  • +36 more
Aug 31, 2021

Advanced Non Small Cell Lung Cancer Trial (Sintilimab, Pemigatinib)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • (no location specified)
Aug 6, 2021

Response to PD-1 Immunotherapy in Patients With NSCLC

Recruiting
  • Advanced Non Small Cell Lung Cancer
    • Brest, France
      CHRU de Brest
    May 10, 2021

    Advanced Non Small Cell Lung Cancer Trial in United States (DV281, Breath Actuated Nebulizer, DV281 (RP2D))

    Completed
    • Advanced Non Small Cell Lung Cancer
    • La Jolla, California
    • +5 more
    Jun 15, 2020

    Advanced Non Small Cell Lung Cancer Trial in Changsha (Apatinib Combined With Vinorelbine)

    Completed
    • Advanced Non Small Cell Lung Cancer
    • Apatinib Combined With Vinorelbine
    • Changsha, Hunan, China
      Hunan Provincal Tumor Hospital
    Feb 12, 2020

    Advanced Non Small Cell Lung Cancer, Uterine Cancer, Soft Tissue Sarcoma Trial in Changsha (PD-1 inhibitor, Apatinib)

    Unknown status
    • Advanced Non Small Cell Lung Cancer
    • +2 more
    • Changsha, Hunan, China
      Hunan cancer Hospital
    Jan 23, 2020

    Advanced Non Small Cell Lung Cancer, Failed Prior Chemo Trial in San Antonio (Tarceva (Trademark) (erlotinib HCl, OSI-774))

    Completed
    • Advanced Non Small Cell Lung Cancer
    • Failed Prior Chemotherapy
    • Tarceva (Trademark) (erlotinib HCl, OSI-774)
    • San Antonio, Texas
      Institute for Drug Development Cancer Therapy and Research Cente
    Feb 6, 2018

    Circulating Tumor Cells Molecular and Phenotypical Profiling

    Unknown status
    • Advanced Non Small Cell Lung Cancer
      • Padova, PD, Italy
        Istituto Oncologico Veneto
      Feb 2, 2018

      Advanced Non Small Cell Lung Cancer Trial in France (Cisplatin, Pemetrexed, Gemcitabine)

      Completed
      • Advanced Non Small Cell Lung Cancer
      • Abbeville, France
      • +90 more
      Jan 12, 2018